The THOR IDE Study (NCT05916950)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to test the Thor system in adult (≥ 18 year old) patients with de novo (new, never treated) calcified lesions in infrainguinal (leg) arteries (peripheral artery disease or PAD). The main question\[s\] it aims to answer are: * Is the Thor system safe in treating these lesions * Does the Thor system work to treat these lesions Participants will: * Receive treatment with the Thor system * Have follow-up visits at Discharge, 30 days, 6 months, and 12 months
Who can join: Review the eligibility criteria below.
Location: St. Helena Hospital — St. Helena, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (29 Sites)
Showing the first 25 of 29 sites.
- St. Helena Hospital — St. Helena, California
- Rocky Mountain Regional VA Medical Center — Aurora, Colorado
- Manatee Memorial Hospital — Bradenton, Florida
- Tallahassee Research Institute — Tallahassee, Florida
- Guardian Research Organization — Winter Park, Florida
- Vascular Institute of the Midwest — Davenport, Iowa
- Cardiovascular Institute of the South — Houma, Louisiana
- Cardiovascular Institute of the South — Lafayette, Louisiana
- The Vascular Care Group — Portland, Maine
- Southcoast Hospitals/Charlton Memorial Hospital — Fall River, Massachusetts
- Vascular Breakthroughs — Leominster, Massachusetts
- Henry Ford St John Hospital — Detroit, Michigan
- Henry Ford Hospital — Detroit, Michigan
- Deborah Heart and Lung Center — Browns Mills, New Jersey
- Heart and Vascular Institute of Central Jersey — New Brunswick, New Jersey
- Atlantic Medical Imaging of New jersey — Vineland, New Jersey
- Mount Sinai Hospital — New York, New York
- New York Presbyterian Hospital/Columbia University Irving Medical Center — New York, New York
- Vascular Solutions of North Carolina — Cary, North Carolina
- Premier Cardiovascular Institute — Fairborn, Ohio
- Ascension St. John — Bartlesville, Oklahoma
- UPMC — Mechanicsburg, Pennsylvania
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
- Lankenau Institute for Medical Research — Wynnewood, Pennsylvania
- The Miriam Hospital — Providence, Rhode Island
📞 Contact the Study Coordinator
Phone: +31 (0)6 27218737
Email: Danielle.op.den.kamp@philips.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peripheral Artery Disease
- Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform in Correlation to TcPO2 — San Francisco, California
- Far Red Light to Improve Functioning in PAD — Birmingham, Alabama
- Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease — Chicago, Illinois
- Telehealth to Improve Functional Status and Quality of Life in Veterans With PAD — Durham, North Carolina
- BEETroot Juice to Reverse Functional Impairment in PAD — Chicago, Illinois
- Exercise Therapy for PAD Using Mobile Health — Decatur, Georgia
Explore by condition: All Peripheral Artery Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.